Cargando…
Perioperative risk assessment with Euroscore and Euroscore II in patients with coronary artery or valvular disease
Nowadays, both the European System for Cardiac Operative Risk Evaluation (EuroSCORE) logistic (ESL) and EuroSCORE II (ESII) models are used worldwide in predicting in-hospital mortality after cardiac operation. However, these scales are based on different populations and represent different medical...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320047/ https://www.ncbi.nlm.nih.gov/pubmed/30558022 http://dx.doi.org/10.1097/MD.0000000000013572 |
_version_ | 1783385158430228480 |
---|---|
author | Czub, Paweł Cacko, Andrzej Gawałko, Monika Tataj, Emanuel Poliński, Jakub Pawlik, Kacper Cichoń, Romuald Hendzel, Piotr |
author_facet | Czub, Paweł Cacko, Andrzej Gawałko, Monika Tataj, Emanuel Poliński, Jakub Pawlik, Kacper Cichoń, Romuald Hendzel, Piotr |
author_sort | Czub, Paweł |
collection | PubMed |
description | Nowadays, both the European System for Cardiac Operative Risk Evaluation (EuroSCORE) logistic (ESL) and EuroSCORE II (ESII) models are used worldwide in predicting in-hospital mortality after cardiac operation. However, these scales are based on different populations and represent different medical approaches. The aim of the study was to assess the effectiveness of the ESL and the ESII risk scores in predicting in-hospital death and prolonged hospitalization in intensive care unit (ICU) after coronary artery bypass grafting (CABG), aortic valve replacement (AVR), and mitral valve replacement (MVR) by comparison of an estimated risk and a real-life observation at a reference cardiac surgery unit. This retrospective study was based on medical records of patients who underwent a CABG, AVR, or MVR at a reference cardiac surgery unit in a 2-year period. Primary endpoint was defined as in-hospital death. Secondary endpoint was a prolonged hospitalization at the ICU, defined as longer than 3 days. The study encompassed 586 patients [114 (23.1%) female, mean age 65.8 ± 10.5 years], including 493 patients undergoing CABG, 66 patients undergoing AVR, and 27 patients undergoing MVR. The ESL and ESII risk scores were higher in MVR subgroup (31.7% ± 30.5% and 15.3% ± 19.4%) and AVR subgroup (9.7% ± 11.6% and 3.2% ± 4.2%) than in CABG subgroup (6.9% ± 10.4% and 2.5% ± 4.1%; P < .001). Subgroups of patients were significantly different in terms of clinical, biochemical, and echocardiography factors. Primary endpoint occurred in 36 (6.1%) patients: 21 (4.3%), 7 (10.6%), and 8 (29.7%) in CABG, AVR, and MVR subgroups, respectively. The ESII underestimated the risk of mortality. Secondary endpoint occurred in 210 (35.8%) patients: 172 (34.9%), 22 (33.4%), and 16 (59.3%) in CABG, AVR, and MVR subgroups, respectively. In the study, the perioperative risk estimated with the ESL and the ESII risk scores was compared with a real-life outcome among over 500 patients. Regardless of the type of surgery, result in the ESL was better correlated with the risk of in-hospital death. |
format | Online Article Text |
id | pubmed-6320047 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-63200472019-01-24 Perioperative risk assessment with Euroscore and Euroscore II in patients with coronary artery or valvular disease Czub, Paweł Cacko, Andrzej Gawałko, Monika Tataj, Emanuel Poliński, Jakub Pawlik, Kacper Cichoń, Romuald Hendzel, Piotr Medicine (Baltimore) Research Article Nowadays, both the European System for Cardiac Operative Risk Evaluation (EuroSCORE) logistic (ESL) and EuroSCORE II (ESII) models are used worldwide in predicting in-hospital mortality after cardiac operation. However, these scales are based on different populations and represent different medical approaches. The aim of the study was to assess the effectiveness of the ESL and the ESII risk scores in predicting in-hospital death and prolonged hospitalization in intensive care unit (ICU) after coronary artery bypass grafting (CABG), aortic valve replacement (AVR), and mitral valve replacement (MVR) by comparison of an estimated risk and a real-life observation at a reference cardiac surgery unit. This retrospective study was based on medical records of patients who underwent a CABG, AVR, or MVR at a reference cardiac surgery unit in a 2-year period. Primary endpoint was defined as in-hospital death. Secondary endpoint was a prolonged hospitalization at the ICU, defined as longer than 3 days. The study encompassed 586 patients [114 (23.1%) female, mean age 65.8 ± 10.5 years], including 493 patients undergoing CABG, 66 patients undergoing AVR, and 27 patients undergoing MVR. The ESL and ESII risk scores were higher in MVR subgroup (31.7% ± 30.5% and 15.3% ± 19.4%) and AVR subgroup (9.7% ± 11.6% and 3.2% ± 4.2%) than in CABG subgroup (6.9% ± 10.4% and 2.5% ± 4.1%; P < .001). Subgroups of patients were significantly different in terms of clinical, biochemical, and echocardiography factors. Primary endpoint occurred in 36 (6.1%) patients: 21 (4.3%), 7 (10.6%), and 8 (29.7%) in CABG, AVR, and MVR subgroups, respectively. The ESII underestimated the risk of mortality. Secondary endpoint occurred in 210 (35.8%) patients: 172 (34.9%), 22 (33.4%), and 16 (59.3%) in CABG, AVR, and MVR subgroups, respectively. In the study, the perioperative risk estimated with the ESL and the ESII risk scores was compared with a real-life outcome among over 500 patients. Regardless of the type of surgery, result in the ESL was better correlated with the risk of in-hospital death. Wolters Kluwer Health 2018-12-14 /pmc/articles/PMC6320047/ /pubmed/30558022 http://dx.doi.org/10.1097/MD.0000000000013572 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 |
spellingShingle | Research Article Czub, Paweł Cacko, Andrzej Gawałko, Monika Tataj, Emanuel Poliński, Jakub Pawlik, Kacper Cichoń, Romuald Hendzel, Piotr Perioperative risk assessment with Euroscore and Euroscore II in patients with coronary artery or valvular disease |
title | Perioperative risk assessment with Euroscore and Euroscore II in patients with coronary artery or valvular disease |
title_full | Perioperative risk assessment with Euroscore and Euroscore II in patients with coronary artery or valvular disease |
title_fullStr | Perioperative risk assessment with Euroscore and Euroscore II in patients with coronary artery or valvular disease |
title_full_unstemmed | Perioperative risk assessment with Euroscore and Euroscore II in patients with coronary artery or valvular disease |
title_short | Perioperative risk assessment with Euroscore and Euroscore II in patients with coronary artery or valvular disease |
title_sort | perioperative risk assessment with euroscore and euroscore ii in patients with coronary artery or valvular disease |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320047/ https://www.ncbi.nlm.nih.gov/pubmed/30558022 http://dx.doi.org/10.1097/MD.0000000000013572 |
work_keys_str_mv | AT czubpaweł perioperativeriskassessmentwitheuroscoreandeuroscoreiiinpatientswithcoronaryarteryorvalvulardisease AT cackoandrzej perioperativeriskassessmentwitheuroscoreandeuroscoreiiinpatientswithcoronaryarteryorvalvulardisease AT gawałkomonika perioperativeriskassessmentwitheuroscoreandeuroscoreiiinpatientswithcoronaryarteryorvalvulardisease AT tatajemanuel perioperativeriskassessmentwitheuroscoreandeuroscoreiiinpatientswithcoronaryarteryorvalvulardisease AT polinskijakub perioperativeriskassessmentwitheuroscoreandeuroscoreiiinpatientswithcoronaryarteryorvalvulardisease AT pawlikkacper perioperativeriskassessmentwitheuroscoreandeuroscoreiiinpatientswithcoronaryarteryorvalvulardisease AT cichonromuald perioperativeriskassessmentwitheuroscoreandeuroscoreiiinpatientswithcoronaryarteryorvalvulardisease AT hendzelpiotr perioperativeriskassessmentwitheuroscoreandeuroscoreiiinpatientswithcoronaryarteryorvalvulardisease |